Eli Lilly to invest $450 million more to expand capacity as obesity drug decision looms
The company has been struggling to meet strong demand for its incretin products, which include its diabetes drug Trulicity and…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.